[Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
D000433:1-Propanol / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000605:Amino Alcohols / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D003326:Coronary Circulation / Q000187:drug effects; D003408:Cresols / Q000494:pharmacology; D004176:Dipyridamole / Q000008:administration & dosage / Q000494:pharmacology*; D004285:Dogs; D004338:Drug Combinations; D005260:Female; D005263:Femoral Artery; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D010100:Oxygen / Q000097:blood; D011437:Propylamines / Q000494:pharmacology; D051381:Rats
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D003408:Cresols; D004338:Drug Combinations; D011437:Propylamines; D004176:Dipyridamole; D000433:1-Propanol; D007545:Isoproterenol; D010100:Oxygen
Pharmakologische Untersuchung der Kombination einer koronardilatierenden mit einer beta-rezeptorenblockierenden Substanz.